10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Oramed Pharmaceuticals Inc - Trending symbols

Latest News of Oramed Pharmaceuticals Inc

DateTitleRead
2025-08-21
22:13
Form 8K Oramed Pharmaceuticals Inc For: 21 AugustRead

Notifications

TypeNotificationDate
RSI OverboughtOverbought RSI (Relative Strength Index)2025-09-12



Trends

 2024-06-302024-09-302024-12-312025-03-312025-06-30
Tax Provision 1,634-5011,133-717416168584-710-126
Income Tax Expense 1,634-5011,133-717416168584-710-126
Income before Tax -14,0552,544-11,511-11,478-22,989-14,675-37,66442,7525,088
Net Income -14,3552,844-11,511-10,727-22,238-15,526-37,76443,2895,525
Net Debt -3,329-15,892-19,221-57,491-76,71237,142-39,57082,13742,567
Net Income from Continuing Operations -8,7365,125-3,6112,298-1,313-1,971-3,28416,58013,296
Net Interest Income 1,0365981,634-371,5978812,478-2,869-391
Long-term Assets 28,662-1,24127,421-23,1564,2652684,533-157,109-152,576
EBITDA -9,870-298-10,1684,259-5,909-3,814-9,72346,40136,678
Minority Interest 1,07701,07701,077-744333-541-208

Comments

How you think about this?

Leave a comment

Stay informed about Oramed Pharmaceuticals Inc.

Receive notifications about Oramed Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.